ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)
During the Trading Day
| 2.20 |  +0.03 / +1.38% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 2.20 |  0.00 / 0.00% |
Volume: 2.5K |
Latest IMUC News | Press Releases
No recent news for ImmunoCellular Therapeutics Ltd.
Today’s Trading
| Previous close | 2.17 |
| Today’s open | 2.20 |
| Day’s range | 2.16 - 2.25 |
| Volume | 420,809 |
| Average volume (3 months) | 481,416 |
| Market cap | $114.4M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | -66.67% |
| Earnings growth (this year) | +16.43% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ONTYOncothyreon Inc | -0.02 | -0.84% |
| BSTCBiospecifics Technol... | +0.05 | +0.31% |
| CDXSCodexis Inc | -0.05 | -1.88% |
| ENZEnzo Biochem Inc | +0.09 | +4.09% |
Data as of 4:04pm ET, 06/18/2013
Financials
| Next reporting date | August 14, 2013 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$14.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Scientific Officer John S. Yu, MD |
President, Chief Executive Officer & Director Andrew Gengos, MBA |
Corporate headquarters Woodland Hills, California |
Forecasts
